Canada Halts J&J Vaccine Rollout Amid Disastrous Mix-up at Maryland Lab

Share

The most important difference between the J & J vaccine and the Pfizer, Moderna and AstraZeneca vaccines is that it requires just one dose.

Denmark has said it will not use U.S. drugmaker Johnson & Johnson's single-shot Covid-19 vaccine in its vaccination campaign, citing concerns over serious side effects involving blood clots.

He said some doses would be held back to be used in hospital settings for people who normally wouldn't be caught up in the vaccination process.

Caren Diltz administers the vaccine Friday to UNOH student Chris Pelletier, of Lima, during the clinic at the Knights of Columbus Hall on Cable Road. These all use the virus' genetic code to promote an antibody response, but enter the cells differently.

As was the case with the AstraZeneca jab, the vaccine will be axed due to concerns relating to serious blood clots.

The FDA halted production of the vaccines at a US manufacturing plant owned by Emergent BioSolutions earlier this month as it investigates an error that led to millions of doses being ruined in March.

New York City aims to 'fully reopen' on July 1
De Blasio said there was still "work to be done" and said the key to reopening would be getting everybody vaccinated. State lawmakers in Albany have already said restrictions on bars and restaurants will be lifted in May.

The European Union also approved the drug last month and has ordered 400 million doses.

Health Canada has paused the distribution of the Johnson & Johnson coronavirus vaccine after discovering that it was manufactured at the same Maryland plant which screwed up the ingredients in some 15 million doses of the jab meant for the United States market, ruining them.

The Emergent Biosolutions facility in Baltimore was recently cited by the US Food and Drug Administration for violations including cleaning and sterilisation failures, the potential for cross-contamination, and failure to follow required protocols.

The doses arrived in Canada on Wednesday.

As a result, Health Canada won't release the doses until it's satisfied they meet quality, safety and efficacy standards.

Health Canada's pause on the J&J shot is a setback for the country's efforts to continue ramping up vaccinations amid a raging third wave of the pandemic. That means B.C., with around 13 per cent of the national population, is in line for around 40,000 doses from the first shipment.

Share